Skip to main content
Top
Published in: Medical Oncology 3/2012

01-09-2012 | Original Paper

Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient

Authors: Chengcheng Gao, Liqun Pang, Chengcheng Ren, Tianheng Ma

Published in: Medical Oncology | Issue 3/2012

Login to get access

Abstract

The neural precursor cell expressed, developmentally down-regulated 4-like (Nedd4L) gene encodes an ubiquitin ligase that targets the epithelial sodium channel for degradation. Recent studies have demonstrated that Nedd4L plays a role in the progression of various cancers. However, the clinical implications of Nedd4L expression status in gastric cancer have remained unclear. We examined the Nedd4L expression in 82 gastric cancer patients by immunohistochemistry. The correlation between Nedd4L expression and clinicopathological factors, including prognosis, was evaluated. Cancerous Nedd4L expression was detectable in 36 of the 82 tumors (43.9%). Tumors with negative Nedd4L expression had greater extent of lymph node metastasis, lymphatic invasion, and venous invasion, and were at a worse stage than the tumors with positive Nedd4L expression. Additionally, the patients with negative Nedd4L expression had poor clinical outcomes. Furthermore, multivariate analysis indicated that Nedd4L expression was an independent prognostic factor for gastric cancer patients. Our results suggest for the first time that negative Nedd4L expression is strongly related to the invasion and metastasis of gastric cancer. Therefore, Nedd4L expression can be used as an independent prognostic marker of gastric cancer.
Literature
1.
go back to reference Atmaca A, Pauligk C, Steinmetz K, et al. Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer. Oncology. 2011;80:130–4.PubMedCrossRef Atmaca A, Pauligk C, Steinmetz K, et al. Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer. Oncology. 2011;80:130–4.PubMedCrossRef
2.
go back to reference Ye YW, Dong RZ, Zhou Y, et al. Prognostic analysis of familial gastric cancer in Chinese population. J Surg Oncol. 2011;104:76–82.PubMedCrossRef Ye YW, Dong RZ, Zhou Y, et al. Prognostic analysis of familial gastric cancer in Chinese population. J Surg Oncol. 2011;104:76–82.PubMedCrossRef
3.
go back to reference Zhang YZ, Zhang LH, Gao Y, et al. Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol. 2011;17:1710–7.PubMedCrossRef Zhang YZ, Zhang LH, Gao Y, et al. Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol. 2011;17:1710–7.PubMedCrossRef
4.
go back to reference Chen H, Ross CA, Wang N, et al. NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4–2 gene. Eur J Hum Genet. 2001;9:922–30.PubMedCrossRef Chen H, Ross CA, Wang N, et al. NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4–2 gene. Eur J Hum Genet. 2001;9:922–30.PubMedCrossRef
5.
go back to reference Dunn DM, Ishigami T, Pankow J, et al. Common variant of human NEDD4L activates a cryptic splice site to form a frameshifted transcript. J Hum Genet. 2002;47:665–76.PubMedCrossRef Dunn DM, Ishigami T, Pankow J, et al. Common variant of human NEDD4L activates a cryptic splice site to form a frameshifted transcript. J Hum Genet. 2002;47:665–76.PubMedCrossRef
6.
go back to reference Flasza M, Gorman P, Roylance R, et al. Alternative splicing determines the domain structure of WWP1, a Nedd4 family protein. Biochem Biophys Res Commun. 2002;290:431–7.PubMedCrossRef Flasza M, Gorman P, Roylance R, et al. Alternative splicing determines the domain structure of WWP1, a Nedd4 family protein. Biochem Biophys Res Commun. 2002;290:431–7.PubMedCrossRef
7.
go back to reference Takeuchi T, Adachi Y, Nagayama T, et al. Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer. Int J Exp Pathol. 2011;92:79–86.PubMedCrossRef Takeuchi T, Adachi Y, Nagayama T, et al. Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer. Int J Exp Pathol. 2011;92:79–86.PubMedCrossRef
8.
go back to reference Hu XY, Xu YM, Fu Q, et al. Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia. Eur J Surg Oncol. 2009;35:527–31.PubMedCrossRef Hu XY, Xu YM, Fu Q, et al. Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia. Eur J Surg Oncol. 2009;35:527–31.PubMedCrossRef
9.
go back to reference Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley, International Union Against Cancer; 2002. Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley, International Union Against Cancer; 2002.
10.
go back to reference Lee HS, Park MH, Yang SJ, et al. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Life Sci. 2007;80:690–8.PubMedCrossRef Lee HS, Park MH, Yang SJ, et al. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Life Sci. 2007;80:690–8.PubMedCrossRef
11.
go back to reference Wyatt L, Wadham C, Crocker LA, et al. The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol. 2007;178:1223–35.PubMedCrossRef Wyatt L, Wadham C, Crocker LA, et al. The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol. 2007;178:1223–35.PubMedCrossRef
12.
go back to reference Qi H, Grenier J, Fournier A, et al. Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells. Mol Cell Endocrinol. 2003;210:51–62.PubMedCrossRef Qi H, Grenier J, Fournier A, et al. Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells. Mol Cell Endocrinol. 2003;210:51–62.PubMedCrossRef
13.
go back to reference Hellwinkel OJ, Asong LE, Rogmann JP, et al. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma. Prostate Cancer Prostatic Dis. 2011;14:38–45.PubMedCrossRef Hellwinkel OJ, Asong LE, Rogmann JP, et al. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma. Prostate Cancer Prostatic Dis. 2011;14:38–45.PubMedCrossRef
Metadata
Title
Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient
Authors
Chengcheng Gao
Liqun Pang
Chengcheng Ren
Tianheng Ma
Publication date
01-09-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 3/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-0061-3

Other articles of this Issue 3/2012

Medical Oncology 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.